跳至主要内容
临床试验/NCT05728125
NCT05728125尚未招募不适用

An In Depth Study Evaluating The Experiences of Patients In Glioblastoma Clinical Trials

Power Life Sciences Inc.0 个研究点目标入组 500 人开始时间: 2024年3月最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
500
主要终点
Rate of patients who remain in glioblastoma clinical trial to trial completion

研究概览

简要总结

Historically, clinical study participation has been biased toward certain demographics. However, there is a shortage of studies that delve into the underlying factors that influence patient participation, both positively and negatively.

Several people will be invited to enroll in this study so that it may collect a variety of data about glioblastoma clinical trial experiences and identify barriers to participation as well as the causes of participants' failure or withdrawal.

The data collected from this study will be analyzed and used to improve the experiences of future glioblastoma patients who are recruited for medical trials.

研究设计

研究类型
Observational
观察模型
Case Crossover
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient has self-identified as planning to enroll in a clinical trial
  • Patient has been diagnosed with glioblastoma
  • Patient is a minimum of 18 years or older

排除标准

  • Patient does not understand, sign, and return consent form
  • Inability to perform regular electronic reporting
  • Patient is pregnant

结局指标

主要结局

Rate of patients who remain in glioblastoma clinical trial to trial completion

时间窗: 12 months

Number of patients who decide to participate in a glioblastoma clinical trial

时间窗: 3 months

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

相似试验